BioCryst Pharmaceuticals, Inc. (BCRX)
9.67
+0.12
(+1.26%)
USD |
NASDAQ |
Aug 24, 16:00
9.77
+0.10
(+1.03%)
After-Hours: 20:00
BioCryst Pharmaceuticals Total Assets (Quarterly) : 557.85M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 557.85M |
| March 31, 2026 | 465.05M |
| December 31, 2025 | 514.16M |
| September 30, 2025 | 446.42M |
| June 30, 2025 | 457.19M |
| March 31, 2025 | 480.05M |
| December 31, 2024 | 490.42M |
| September 30, 2024 | 491.25M |
| June 30, 2024 | 472.42M |
| March 31, 2024 | 467.89M |
| December 31, 2023 | 516.96M |
| September 30, 2023 | 522.92M |
| June 30, 2023 | 529.88M |
| March 31, 2023 | 509.74M |
| December 31, 2022 | 550.00M |
| September 30, 2022 | 558.59M |
| June 30, 2022 | 510.54M |
| March 31, 2022 | 527.72M |
| December 31, 2021 | 588.15M |
| September 30, 2021 | 265.76M |
| June 30, 2021 | 277.28M |
| March 31, 2021 | 284.43M |
| December 31, 2020 | 334.72M |
| September 30, 2020 | 176.23M |
| June 30, 2020 | 214.71M |
| Date | Value |
|---|---|
| March 31, 2020 | 136.59M |
| December 31, 2019 | 175.28M |
| September 30, 2019 | 90.50M |
| June 30, 2019 | 116.34M |
| March 31, 2019 | 142.34M |
| December 31, 2018 | 146.84M |
| September 30, 2018 | 168.31M |
| June 30, 2018 | 136.64M |
| March 31, 2018 | 155.37M |
| December 31, 2017 | 178.26M |
| September 30, 2017 | 191.49M |
| June 30, 2017 | 113.51M |
| March 31, 2017 | 129.51M |
| December 31, 2016 | 89.85M |
| September 30, 2016 | 91.50M |
| June 30, 2016 | 82.22M |
| March 31, 2016 | 102.88M |
| December 31, 2015 | 124.56M |
| September 30, 2015 | 138.96M |
| June 30, 2015 | 150.18M |
| March 31, 2015 | 129.87M |
| December 31, 2014 | 136.87M |
| September 30, 2014 | 137.12M |
| June 30, 2014 | 141.98M |
| March 31, 2014 | 43.39M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Amgen, Inc. | 95.64B |
| Vertex Pharmaceuticals, Inc. | 27.42B |
| Agenus, Inc. | 172.69M |
| Anika Therapeutics, Inc. | 183.47M |
| Imunon, Inc. | 14.99M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.012B |
| Shareholders Equity (Quarterly) | -454.29M |
| Debt to Equity Ratio | -1.842 |
| Current Ratio | 2.321 |
| Net Debt Paydown Yield | -0.06% |